Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ling-Hsiang Chuang

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Pharmacoeconomics|July 31, 2009
Converting the SF-12 into the EQ-5D: an empirical comparison of methodologiesLing-Hsiang Chuang, Paul Kind
Medical Decision Making : an International Journal of the Society for Medical Decision Making|July 31, 2010
The effect of health state selection on the valuation of EQ-5DLing-Hsiang Chuang, Paul Kind
British Medical Bulletin|January 3, 2012
Mapping for economic evaluationLing-Hsiang Chuang, Sarah J Whitehead
Medical Care|January 27, 2009
Estimating Domestic Values for EQ-5D Health States Using Survey Data From External SourcesLing-Hsiang Chuang, Victor Zarate, Paul Kind
BMC Public Health|October 1, 2025
Self-reported health status in the general population over 2 decades: variation in EQ-5D-3L in Health Survey for EnglandLing-Hsiang Chuang, Ranjeeta Thomas, Paul Kind
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|March 8, 2013
Comparative responsiveness and minimal change of the Knee Quality of Life 26-item (KQoL-26) questionnaireLing-Hsiang Chuang, Andrew Garratt, Stephen Brealey
Journal of Medical Economics|December 20, 2021
Cost-effectiveness of brentuximab vedotin for relapsed or refractory systemic anaplastic large-cell lymphoma in ChinaJia Liu, Lei Zheng, Ling-Hsiang Chuang
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2008
Hispanic valuation of the EQ-5D health states: a social value set for Latin AmericansVictor Zarate, Paul Kind, Ling-Hsiang Chuang
BMC Medical Research Methodology|September 12, 2014
Network meta-analysis of (individual patient) time to event data alongside (aggregate) count dataPedro Saramago, Ling-Hsiang Chuang, Marta O Soares
Health Economics Review|June 6, 2024
Cost-effectiveness of brentuximab vedotin compared with conventional chemotherapy for relapsed or refractory classic Hodgkin lymphoma in ChinaShitong Xie, Yanan Sheng, Ling-Hsiang Chuang, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Pharmacoeconomics|July 31, 2009
Converting the SF-12 into the EQ-5D: an empirical comparison of methodologiesLing-Hsiang Chuang, Paul Kind
Medical Decision Making : an International Journal of the Society for Medical Decision Making|July 31, 2010
The effect of health state selection on the valuation of EQ-5DLing-Hsiang Chuang, Paul Kind
British Medical Bulletin|January 3, 2012
Mapping for economic evaluationLing-Hsiang Chuang, Sarah J Whitehead
Medical Care|January 27, 2009
Estimating Domestic Values for EQ-5D Health States Using Survey Data From External SourcesLing-Hsiang Chuang, Victor Zarate, Paul Kind
BMC Public Health|October 1, 2025
Self-reported health status in the general population over 2 decades: variation in EQ-5D-3L in Health Survey for EnglandLing-Hsiang Chuang, Ranjeeta Thomas, Paul Kind
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|March 8, 2013
Comparative responsiveness and minimal change of the Knee Quality of Life 26-item (KQoL-26) questionnaireLing-Hsiang Chuang, Andrew Garratt, Stephen Brealey
Journal of Medical Economics|December 20, 2021
Cost-effectiveness of brentuximab vedotin for relapsed or refractory systemic anaplastic large-cell lymphoma in ChinaJia Liu, Lei Zheng, Ling-Hsiang Chuang
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2008
Hispanic valuation of the EQ-5D health states: a social value set for Latin AmericansVictor Zarate, Paul Kind, Ling-Hsiang Chuang
BMC Medical Research Methodology|September 12, 2014
Network meta-analysis of (individual patient) time to event data alongside (aggregate) count dataPedro Saramago, Ling-Hsiang Chuang, Marta O Soares
Health Economics Review|June 6, 2024
Cost-effectiveness of brentuximab vedotin compared with conventional chemotherapy for relapsed or refractory classic Hodgkin lymphoma in ChinaShitong Xie, Yanan Sheng, Ling-Hsiang Chuang, et al.
Pageof 4